Introduction to Pharmacology! What is Pharmacology and How do Drugs Act? Flashcards

1
Q

What is pharmacology?

A

The study of the effects of drugs on the function of living systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a drug?

A

A chemical substance of known structure, other than a nutrient or an essential dietary ingredient, which, when administered to a living organism, produces a biological effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why did pythagoroas not eat beans?

A

— fava bean ingestion was dangerous for some
* now known to be G6PDH deficient individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What did Robert Boyles do for pharmacology?

A
  • He kinda just made shit up
    — Surprisingly content with lack of scientific approach to therapeutics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What did Benjamin Franklin bring to the US?

A

– world traveler and gout sufferer; introduced colchicine to the U.S.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What did Paul Ehrlich do for pharmacology?

A

Modern Chemotherapy
— How to differentiate healthy tissue from invading pathogen
— Staining techniques led eventually to Gram staining
— arsphenamine (Salvasan)
* Treatment of syphilis
— 1908 Nobel Prize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What did Gerhard Domagk do for pharmacology?

A
  • 1908
    — synthesis of azo dyes
  • 1932
    — Klarer & Mietzsch
  • patent for azo dyes containing sulfonamide group
    — Domagk studied synthetic azo dyes for action against Streptococci and Staphylococci
  • 1933
    — Prontosil (a red dye with the active metabolite = sulfanilamide) given to 10 month old infant with Staph septicemia
  • dramatic cure, but little credit given
    — Domagk treats his own daughter with prontosil
  • dramatic cure, but he doesn’t tell anyone until later
  • 1939
    — Nobel Prize awarded to Domagk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What did Alexander Fleming do for pharamcology?

A
  • Staphylococcus cultures contaminated with mold
  • Crude mold extract administered to Strep. infected mice
  • Crude drug recovered in urine (people)
    ▪ Mold identified as Penicillium notatum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is important to know about the Food and Drug Administration (FDA)?

A
  • U.S. Food & Drug Administration (FDA) created in 1938
  • Over 1,500 “drugs” have been reviewed and approved by the FDA
  • Many drugs in wide use prior to FDA
    — aspirin, colchicine, morphine, etc
  • On average, 25-30 New Molecular Entities (NME) approved by FDA every year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is PKPD?

A

Pharmacokinetics & Pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is pharmacokinetics?

A
  • Absorption
  • Distribution
  • Metabolism
  • Excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is pharmacodynamics (part of pharmacology)?

A
  • Drug-receptor interactions
  • Signal transduction
  • Drug effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is pharmacogenetics (part of pharmacology)?

A
  • the metabolic fate of a drug based on individual genetic differences
  • study of genetic influences on the responses to drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is pharmacogenomics?

A
  • the genetic basis of a drug’s absorption, distribution, metabolism, excretion, and receptor-target affinity
    — the genetic basis of a drug’s pharmacokinetics and
    pharmacodynamics
    — an extension of pharmacogenetics
  • use of genetic information to guide the choice of drug therapy on an individual basis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is pharmacoepidemiology?

A
  • The study of drug effects at the population level
  • Concerned with variability of drug effects between individuals in a population and between populations
  • Made possible with “Big Data” sets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is pharmacoeconomics?

A
  • The study of cost and benefits/detriments of drugs used clinically
  • Made possible with “Big Data” sets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are all the branches of pharmacology?

A
  • Biochemistry & Biotechnology
  • Physiology & Pathophysiology
  • Chemistry Medicinal Chemistry
  • Pharmacogenetics & Pharmacogenomics
  • Pharmacoepidemiology
  • Pharmaceutics
  • Pharmacoeconomics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does the FDA do?

A

— administrative body that oversees drug evaluation process
* FDA grants approval for marketing new drug products
— evidence of safety and efficacy
— “safe” does not mean complete absence of risk
* FDA and USDA
— FDA shares responsibility with USDA for food safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the dietary supplement health and education act (1994)?

A

— prohibited full FDA review of supplements and botanicals as drugs
— established labeling requirements for dietary supplements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is “drug” as defined by FDA?

A
  • A substance (other than food) recognized by an official pharmacopoeia or formulary intended:
    — for use in the diagnosis, cure, mitigation, treatment, or prevention of disease
    — to affect the structure or any function of the body
    — for use as a component of a medicine but not a device
  • Biological products are included within this definition and are generally covered by the same laws and regulations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is a generic drug?

A

A generic drug is the same as a brand name drug in dosage, safety, strength, how it is taken, quality, performance, and intended use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the steps of drug development process?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What did Pual Ehrlich believe in developing?

A

Magic Bullet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the protein targets for drug binding?

A
  • Receptors
  • Enzymes
  • Carrier Molecules (Transporters)
  • Ion Channels
  • Specific Circulating Plasma Proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the nucleic acid targets for drug binding?

A
  • RNA & DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are receptors?

A
  • Protein molecules which function to recognize and respond to endogenous chemical signals
  • Classified based on ligands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the receptors (G-protein coupled) in the autonomic nervous system?

A

Adrenergic Receptors
— a1, a2, B1, B2, B3
Cholinergic
—muscarinic (M)

28
Q

What are the receptors (G-protein coupled) in the vascular system?

A

— angiotensin II receptors (AT1, AT2)
— endothelin receptors (ETA, ETB)
— prostaglandin receptors (DP, EP, FP, IP, TP)
— histamine receptors (H1, H2, H3)

29
Q

What are nuclear receptors?

A
  • Steroid Receptors
    —Estrogen Receptor (ERa, ERB)
    —Androgen Receptor
    —Glucocorticoid Receptor (cortisol)
    —Mineralocorticoid Receptor (aldosterone)
    —Retinoid X Receptor (RXR)
    —Constitutive Androstane Receptor (CAR)
30
Q

For a drug to be useful…

A

— must act selectively on particular cells and tissues
— must show a high degree of binding site specificity

31
Q

For a protein to function as a receptor?

A

— generally shows a high degree of ligand specificity
— bind only molecules of certain physicochemical properties (size, shape, charge, lipophilicity)

32
Q

What does angiotensin II do?

A
  • Selectively activates angiotensin II receptors in vascular smooth muscle to cause contraction
  • Angiotensin II receptors selectively bind angiotensin II
33
Q

What is the most common receptor binding?

A

Electrostatic

34
Q

What is the most rare type of receptor binding?

35
Q

What is an electrostatic receptor bond?

A
  • Electrostatic (most common)
    — weaker: hydrogen bonding and van der Waals forces (dipoles)
    — stronger: ionic bonding
36
Q

What is an hydrophobic receptor bond?

A
  • Hydrophobic (less common)
    — weak associations of hydrophobic compounds with hydrophobic domains of receptors
37
Q

What is an covalent receptor bond?

A
  • Covalent (relatively rare)
    — permanent, lasting bonding
    — aspirin and cyclooxygenase
    — omeprazole and proton pump
38
Q

What is lipophilic?

A

— more soluble in oil than water
* i.e. more soluble in fat than blood
— steroids
— readily diffuse across membranes
— more likely to by metabolized by gut and liver

39
Q

What is hydrophilic?

A

— more soluble in water than oil
* i.e. more soluble in blood than fat
— small molecules, weak acids/bases
* ionized at physiologic pH (7.4)
— not as easy to diffuse across plasma membranes
— more likely to be excreted unchanged by kidney

40
Q

___ is the pH at which the concentrations of ionized and unionized species are equal

41
Q

If a drug is chiral (stereoisomeric) what does that mean?

A

— enantiomers: 1 pair for each chiral carbon
— most drugs used as “racemic” mixtures
— sometimes only one stereoisomer is active and the others produce adverse effects

42
Q

What is dissociation constand (Kd)?

A
  • concentration required for 50% saturation of available receptors
  • inversely proportional to affinity
42
Q

What is affinity?

A

— tendency of a drug to bind to the receptor

43
Q

higher the Kd (nM), lower the _________

44
Q

What is efficacy?

A

— tendency of a drug to activate the receptor once bound
— generally expressed as dose-response curves or concentration-effect curves

45
Q

highly effective (potent) drugs generally have _____ affinity

46
Q

What is an agonist?

A

— posses significant efficacy
— full agonist = elicits maximal response
— partial agonist = elicits partial response, even when 100% of receptors are occupied

47
Q

What is an antagonist?

A

— possess zero efficacy

48
Q

What is an alloseric agnosist or antagonist?

A

— bind to the same receptor, but do not prevent binding of the agonist
— may enhance or inhibit the action of agonists

49
Q

On a drug response curve adding an antagonist leads to a _____ shift

A

right
- need more concentratin of agonist for the same effect

50
Q

What are the characteristics of a full agonist?

A

— high affinity for Ra and stabilize Ra on binding
— shift nearly entire pool of receptors from Ri to Ra-D (Ra bound to drug)
— maximal effect is produced

51
Q

What are the characteristics of a partial agonist?

A

— do not stablize Ra as effectively
— significant fraction stays in Ri-D pool
— only partially effective no matter how high concentration
— some can act as agonist or antagonist

52
Q

What are the characteristics of an antagonist?

A

— Ra-D and Ri-D stay in same relative amounts as in the absence of any drug
— no change in effect measured
— block effects of agonist

53
Q

What are the characteristics of an inverse agonist?

A

— higher affinity for Ri than for Ra
— stabilize Ri on binding
— reduces any constitutive activity of receptor thus producing opposite effects as a conventional agonist

54
Q

What is the drug-receptor binding equation in vitro?

A
  • B = drug bound to receptors at given concentration (C)
  • Bmax = point at which at which all receptors are bound
  • Kd = equilibrium dissociation constant or concentration of drug where 50% of receptors are bound
55
Q

What is Kd?

A

equilibrium dissociation constant or concentration of drug where 50% of receptors are bound

56
Q

What is Bmax?

A

point at which at which all receptors are bound

57
Q

What is the concentration-effect equation in vitro/in vivo?

A
  • E = effect observed at given concentration (C)
  • Emax = point at which at which no further effect/response is achieved as “dose” increases further
  • EC50 = concentration of drug that produces 50% of maximal effect/response
58
Q

What is EC50?

A

concentration of drug that produces 50% of maximal effect/response

59
Q

What is Emax?

A

point at which at which no further effect/response is achieved as “dose” increases further

60
Q

What are the characteristics of a competitive antagonist?

A

— bind to same site on receptor as agonist
— compete with agonist for binding
— with fixed agonist concentration, progressive increases in antagonist will progressively decrease effect up to completely abolishing it
— increasing agonist concentration can overcome competitive antagonist

61
Q

What are the characteristics of a noncompetitive antagonist?

A

— often bind covalently and irreversibly
— often allosteric inhibition but can be same binding site as agonist
— increasing agonist concentration may not overcome noncompetitive antagonist

62
Q

What are other mechanisms of drug antagonism besides competitive or noncompetitive?

A
  • chemical antagonist
  • physiologic antagonist
  • pharmacokinetic antagonist
63
Q

How do drug-receptor actions terminate?

A
  • Dissociation of drug from receptor
  • Dissociation of drug from receptor but effects continue for some time
  • Covalently bound drugs require destruction of the drug-receptor complex and synthesis of new receptors
  • Desensitization
64
Q

What happens if there is dissociation of drug from receptor but effects continue for some time?

A

— downstream activation of effectors
— activated effectors have to be deactivated

65
Q

How do drug-receptor actions become desensitized (tachyphylaxis)?

A

— change in receptors
— translocation of receptors
— exhaustion of mediators
— increased drug metabolism
— physiologic adaptation
— active extrusion of drug from cell

66
Q

What are the different timings for drug effects?

A
  • Rapid Responses (seconds to minutes)
  • Intermediate Responses (minutes to hours)
  • Delayed Responses (hours to days)